• Guideline Summary
  • NGC:010331
  • 2014 Feb

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-α–based regimens.

  • Guideline Summary
  • NGC:011000
  • 2016 Apr

Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for UGT1A1 and atazanavir prescribing.

  • Guideline Summary
  • NGC:010001
  • 2013 Jul

Management of cytomegalovirus infection in haemopoietic stem cell transplantation.

  • Guideline Summary
  • NGC:009237
  • 1999 (revised 2012)

ACR Appropriateness Criteria® ataxia.

  • Guideline Summary
  • NGC:009587
  • 2012 Apr (reaffirmed 2014)

Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and abacavir dosing.

Guidelines for the management of hemophilia.

  • Guideline Summary
  • NGC:010530
  • 2014

Health maintenance for people with sickle cell disease. In: Evidence-based management of sickle cell disease.